Target intelligence / Profile preview

PIEZO1 antisense RNA 1 (PIEZO1-AS1)

Target
PIEZO1-AS1
Molecular classification
Long non-coding RNA, Antisense RNA
01

Overview

PIEZO1 antisense RNA 1 (PIEZO1-AS1) is a long non-coding RNA transcribed in the antisense direction at the PIEZO1 gene locus. By its antisense nature, PIEZO1-AS1 may regulate expression of the PIEZO1 mechanosensitive ion channel, potentially via mechanisms such as transcriptional interference, formation of RNA-RNA hybrids, or epigenetic modulation of chromatin structure near the PIEZO1 gene. Unlike PIEZO1, which encodes a clinically significant mechanosensitive ion channel involved in vascular biology, cellular mechanotransduction, and hereditary diseases, PIEZO1-AS1 itself has no known enzymatic, receptor, transporter, or direct signaling activity, and does not serve as a therapeutic drug target at this time. The broader class of antisense RNAs is essential for fine-tuning gene expression in eukaryotes, but individual disease or drug relevance for PIEZO1-AS1 has not been established.

Other names
PIEZO1-AS1
02

Mechanism of action

Not applicable (no direct small molecule, antibody, or therapeutic interactions described)

03

Biological functions

Regulation of gene expressionPotential involvement in transcriptional interference and modulation of PIEZO1 gene levels
04

Disease associations

No direct disease associations established for PIEZO1-AS1; potential indirect roles via regulation of PIEZO1 (implicated in cancer, metastasis, hereditary stomatocytosis)

Beyond the preview

Go deeper on PIEZO1 antisense RNA 1 (PIEZO1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PIEZO1 antisense RNA 1 (PIEZO1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call